News & Events
FDA Approves Xyrem in Pediatric Patients with Narcolepsy
New Survey Identifies the Need For Increased Education and Treatment Options for Narcolepsy
Harmony Biosciences Presented Data On Pitolisant
Research Survey for Parents of Children with Narcolepsy
Pitolisant Granted Breakthrough Therapy and Fast Track Designations by FDA
